Evidence map›Paper›PMID 36654943›Full record

ArticleJHEP reports : innovation in hepatology2023

Impact of waiting time on post-transplant survival for recipients with hepatocellular carcinoma: A natural experiment randomized by blood group.

Berend R Beumer, Wojciech G Polak, Robert A de Man, Herold J Metselaar, David van Klaveren, Jeremy Labrecque, Jan Nm IJzermans

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Berend R BeumerErasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Wojciech G PolakErasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Robert A de ManErasmus MC Transplant Institute, Department of Gastroenterology and Hepatology, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Herold J MetselaarErasmus MC Transplant Institute, Department of Gastroenterology and Hepatology, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
David van KlaverenDepartment of Public Health, Erasmus MC - University Medical Centre, Rotterdam, the Netherlands.
Jeremy LabrecqueDepartment of Epidemiology, Erasmus MC - University Medical Centre, Rotterdam, the Netherlands.
Jan Nm IJzermansErasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Erasmus MC · NLErasmus MC Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: When listing for liver transplantation, one can transplant as soon as possible or introduce a test-of-time to better select patients, as the tumor's biological behavior is observed. Knowing the degree of harm caused by time itself is essential to advise patients and decide on the maximum duration of the test-of-time. Therefore, we investigated the causal effect of waiting time on post-transplant survival for patients with hepatocellular carcinoma. Methods: We analyzed the UNOS-OPTN dataset and exploited a natural experiment created by blood groups. Relations between variables and assumptions were described in a causal graph. Selection bias was addressed by inverse probability weighting. Confounding was avoided using instrumental variable analysis, with an additive hazards model in the second stage. The causal effect was evaluated by estimating the difference in 5-year overall survival if all patients waited 2 months instead of 12 months. Upper bounds of the test-of-time were evaluated for probable scenarios by means of simulation. Results: The F-statistic of the first stage was 86.3. The effect of waiting 12 months Conclusions: From a patient's perspective, the choice between ablate-and-wait Impact and implications: When listing patients with liver cancer for transplantation, it is unclear whether a test-of-time or immediate transplantation offer better outcomes at the population level. In this study, we found that increased liver transplant waiting times are detrimental in patients with liver cancer. Furthermore, our simulation showed that a pre-operative observational period can be useful to ensure good donor liver allocation, but that its duration should not exceed 8 months.

Indexed as

AFP, alpha-fetoproteinALBI score, albumin-bilirubin scoreATE, average treatment effectCausal inferenceHCC, hepatocellular carcinomaHepatocellular carcinomaInstrumental variable analysisIPW, inverse probability weightingLiver transplantationLRT, loco-regional therapyLT, liver transplantationMendelian randomizationOPTN, Organ Procurement and Transplantation NetworkQuasi randomized controlled trialUNOS, United Network for Organ SharingWaiting time

Identifiers

PMID36654943
PMCPMC9841350
OpenAlexW4309693813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.